168 related articles for article (PubMed ID: 4144336)
1. [Adrenergic broncholytic agents. Different causes and symptoms of adverse effects].
Vale JR
Tidsskr Nor Laegeforen; 1972 Dec; 92(35):2442-3. PubMed ID: 4144336
[No Abstract] [Full Text] [Related]
2. Asthma and the beta 2-agonist controversy: much ado about something.
Lieberman JS; Kane GC
Del Med J; 1995 Dec; 67(12):624-8. PubMed ID: 8557164
[No Abstract] [Full Text] [Related]
3. Tolerance to beta-agonists.
Tattersfield AE
Bull Eur Physiopathol Respir; 1985; 21(5):1s-5s. PubMed ID: 2865988
[No Abstract] [Full Text] [Related]
4. [Drug tolerance in asthmatic patients treated with beta adrenergic drugs].
Herjavecz I; Böszórményi ; Nagy G; Szeitz A; Debreczeni L
Orv Hetil; 1985 Sep; 126(39):2401-4, 2407. PubMed ID: 2864677
[No Abstract] [Full Text] [Related]
5. Present state of the controversy about regular inhaled beta-agonists in asthma.
Giuntini CG; Paggiaro PL
Eur Respir J; 1995 May; 8(5):673-8. PubMed ID: 7656934
[No Abstract] [Full Text] [Related]
6. [Beta 2-sympathomimetic drugs].
Criée CP; Laier-Groeneveld G
Internist (Berl); 1995 Sep; 36(9):918-23. PubMed ID: 7591618
[No Abstract] [Full Text] [Related]
7. [Beta-2 adrenergic stimulants in the treatment of asthma: myths and realities].
Maria Y; Moneret-Vautrin DA
Rev Pneumol Clin; 1989; 45(5):185-93. PubMed ID: 2576328
[TBL] [Abstract][Full Text] [Related]
8. Inhaled beta 2-adrenergic agonists in asthma: the evolving dilemma.
Hui KP
Singapore Med J; 1994 Jun; 35(3):237-9. PubMed ID: 7997893
[TBL] [Abstract][Full Text] [Related]
9. Long-acting beta-agonists in asthma.
Knobil K
N Engl J Med; 2009 Jul; 361(2):208-9; author reply 209. PubMed ID: 19593857
[No Abstract] [Full Text] [Related]
10. Adrenergic agonists and bronchodilator aerosol therapy in asthma.
Shim C
Clin Chest Med; 1984 Dec; 5(4):659-68. PubMed ID: 6151440
[TBL] [Abstract][Full Text] [Related]
11. [Interaction between inhaled corticosteroids and long-acting beta-2-agonists].
Kardos P
Dtsch Med Wochenschr; 2009 Dec; 134 Suppl 10():S386-9. PubMed ID: 19941242
[No Abstract] [Full Text] [Related]
12. Study designs of adverse events in asthma treatment.
Ernst P; Suissa S
Eur Respir J; 1992 Jul; 5(7):773-5. PubMed ID: 1354169
[No Abstract] [Full Text] [Related]
13. Salmeterol for the treatment of asthma.
Weinberger M
Ann Allergy Asthma Immunol; 1995 Sep; 75(3):209-11. PubMed ID: 7552921
[No Abstract] [Full Text] [Related]
14. Is the routine use of inhaled beta-adrenergic agonists appropriate in asthma treatment? Yes.
Wanner A
Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 1):597-9. PubMed ID: 7881643
[No Abstract] [Full Text] [Related]
15. Beta-agonist therapy and asthma mortality in Japan.
Beasley R; Nishima S; Pearce N; Crane J
Lancet; 1998 May; 351(9113):1406-7. PubMed ID: 9593418
[No Abstract] [Full Text] [Related]
16. Resistance to beta-adrenoceptor stimulants and death from bronchial asthma.
Blackwell EW; Conolly ME; Davies DS; Dollery CT; George CF
Br J Pharmacol; 1971 Feb; 41(2):410P. PubMed ID: 4396706
[No Abstract] [Full Text] [Related]
17. [The therapeutic potentials of Berotec-100 in bronchial asthma patients].
Emel'ianov AV; Shevelev SE; Shubin SA; Sinitsina TM; Fedoseev GB
Klin Med (Mosk); 1998; 76(7):38-9. PubMed ID: 9742777
[No Abstract] [Full Text] [Related]
18. [Do fixed ICS/LABA-combinations have advantages in terms of patient-centered parameters?].
Buhl R
Dtsch Med Wochenschr; 2009 Dec; 134 Suppl 10():S381-5. PubMed ID: 19941241
[No Abstract] [Full Text] [Related]
19. Is the routine use of inhaled beta-adrenergic agonists appropriate in asthma treatment? No.
Sears MR
Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 1):600-1. PubMed ID: 7881644
[No Abstract] [Full Text] [Related]
20. Whither beta-adrenergic tachyphylaxis?
Jenne JW
J Allergy Clin Immunol; 1982 Dec; 70(6):413-6. PubMed ID: 6128356
[No Abstract] [Full Text] [Related]
[Next] [New Search]
